Literature DB >> 19764029

Complex contributions of Ets2 to craniofacial and thymus phenotypes of trisomic "Down syndrome" mice.

Cheryl A Hill1, Thomas E Sussan, Roger H Reeves, Joan T Richtsmeier.   

Abstract

Ts65Dn mice have segmental trisomy for orthologs of about half of the genes on human chromosome 21, including Ets2. These mice develop anomalies of the cranial skeleton and thymus that parallel those in Down syndrome. Overexpression of the Ets2 transcription factor gene was posited to be sufficient to produce these craniofacial and thymus deficits in transgenic mice that constitutively overexpress a processed Ets2 transcript under a promiscuous promoter [Sumarsono et al. (1996); Nature 379:534-537; Wolvetang et al. (2003); Hum Mol Genet 12:247-255]. Evaluation of trisomic mice with varying copy numbers of a properly regulated Ets2 gene indicated increased dosage of Ets2 was not sufficient to produce effects on thymus and most of the cranial anomalies seen in Ts65Dn mice. However, mesoderm-derived cranial skeletal elements are significantly more affected in Ts65Dn, Ets2(+/-) mice compared to Ts65Dn littermates suggesting a differential interaction of Ets2-related processes with mesoderm-derived and neural crest-derived formative tissues. Our results support the growing evidence for interactions among multiple genes contributing to developmental perturbations resulting in variation in complex Down syndrome phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764029      PMCID: PMC2903219          DOI: 10.1002/ajmg.a.33012

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  23 in total

1.  Ets2 is expressed during morphogenesis of the somite and limb in the mouse embryo.

Authors:  Sika Ristevski; Patrick P L Tam; Paul J Hertzog; Ismail Kola
Journal:  Mech Dev       Date:  2002-08       Impact factor: 1.882

2.  Tissue origins and interactions in the mammalian skull vault.

Authors:  Xiaobing Jiang; Sachiko Iseki; Robert E Maxson; Henry M Sucov; Gillian M Morriss-Kay
Journal:  Dev Biol       Date:  2002-01-01       Impact factor: 3.582

3.  A chromosome 21 critical region does not cause specific Down syndrome phenotypes.

Authors:  L E Olson; J T Richtsmeier; J Leszl; R H Reeves
Journal:  Science       Date:  2004-10-22       Impact factor: 47.728

4.  Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse.

Authors:  L L Baxter; T H Moran; J T Richtsmeier; J Troncoso; R H Reeves
Journal:  Hum Mol Genet       Date:  2000-01-22       Impact factor: 6.150

Review 5.  Ets transcription factors and targets in osteogenesis.

Authors:  A Raouf; A Seth
Journal:  Oncogene       Date:  2000-12-18       Impact factor: 9.867

Review 6.  ETS family of genes in leukemia and Down syndrome.

Authors:  T S Papas; D K Watson; N Sacchi; S Fujiwara; A K Seth; R J Fisher; N K Bhat; G Mavrothalassitis; S Koizumi; C L Jorcyk
Journal:  Am J Med Genet Suppl       Date:  1990

7.  ETS2 overexpression in transgenic models and in Down syndrome predisposes to apoptosis via the p53 pathway.

Authors:  E J Wolvetang; T J Wilson; E Sanij; J Busciglio; T Hatzistavrou; A Seth; P J Hertzog; I Kola
Journal:  Hum Mol Genet       Date:  2003-02-01       Impact factor: 6.150

8.  Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.

Authors:  Pascal Kahlem; Marc Sultan; Ralf Herwig; Matthias Steinfath; Daniela Balzereit; Barbara Eppens; Nidhi G Saran; Mathew T Pletcher; Sarah T South; Gail Stetten; Hans Lehrach; Roger H Reeves; Marie-Laure Yaspo
Journal:  Genome Res       Date:  2004-07       Impact factor: 9.043

9.  What are genes "for" or where are traits "from"? What is the question?

Authors:  Anne V Buchanan; Samuel Sholtis; Joan Richtsmeier; Kenneth M Weiss
Journal:  Bioessays       Date:  2009-02       Impact factor: 4.345

Review 10.  Segmental trisomy as a mouse model for Down syndrome.

Authors:  M T Davisson; C Schmidt; R H Reeves; N G Irving; E C Akeson; B S Harris; R T Bronson
Journal:  Prog Clin Biol Res       Date:  1993
View more
  16 in total

1.  Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.

Authors:  Samantha L Deitz; Randall J Roper
Journal:  Genetics       Date:  2011-09-16       Impact factor: 4.562

Review 2.  Influence of allelic differences in Down syndrome.

Authors:  Randall J Roper; Laura Hawley; Charles R Goodlett
Journal:  Prog Brain Res       Date:  2019-10-24       Impact factor: 2.453

Review 3.  Stem and progenitor cell dysfunction in human trisomies.

Authors:  Binbin Liu; Sarah Filippi; Anindita Roy; Irene Roberts
Journal:  EMBO Rep       Date:  2014-12-17       Impact factor: 8.807

4.  Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome.

Authors:  Samantha D McElyea; John M Starbuck; Danika M Tumbleson-Brink; Emily Harrington; Joshua D Blazek; Ahmed Ghoneima; Katherine Kula; Randall J Roper
Journal:  Hum Mol Genet       Date:  2016-11-15       Impact factor: 6.150

5.  Double deletion of Panx1 and Panx3 affects skin and bone but not hearing.

Authors:  J M Abitbol; B L O'Donnell; C B Wakefield; E Jewlal; J J Kelly; K Barr; K E Willmore; B L Allman; S Penuela
Journal:  J Mol Med (Berl)       Date:  2019-03-27       Impact factor: 4.599

6.  Unilateral Loss of Maxillary Molars in Young Mice Leads to Bilateral Condylar Adaptation and Degenerative Disease.

Authors:  Christopher Phillip Chen; Jiehua Zhang; Bin Zhang; Mohamed G Hassan; Kyle Hane; Caroline C Chen; Ana Alejandra Navarro Palacios; Sunil Kapila; Andrew H Jheon; Alice F Goodwin
Journal:  JBMR Plus       Date:  2022-07-03

Review 7.  Down syndrome: searching for the genetic culprits.

Authors:  Eva Lana-Elola; Sheona D Watson-Scales; Elizabeth M C Fisher; Victor L J Tybulewicz
Journal:  Dis Model Mech       Date:  2011-09       Impact factor: 5.758

8.  Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome.

Authors:  Arnaud Duchon; Matthieu Raveau; Claire Chevalier; Valérie Nalesso; Andrew J Sharp; Yann Herault
Journal:  Mamm Genome       Date:  2011-09-28       Impact factor: 2.957

9.  The use of mouse models for understanding the biology of down syndrome and aging.

Authors:  Guido N Vacano; Nathan Duval; David Patterson
Journal:  Curr Gerontol Geriatr Res       Date:  2012-02-23

10.  Identification of Chiari Type I Malformation subtypes using whole genome expression profiles and cranial base morphometrics.

Authors:  Christina A Markunas; Eric Lock; Karen Soldano; Heidi Cope; Chien-Kuang C Ding; David S Enterline; Gerald Grant; Herbert Fuchs; Allison E Ashley-Koch; Simon G Gregory
Journal:  BMC Med Genomics       Date:  2014-06-25       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.